This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.
Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.
Congratulations to our top 5 recruiting centres:
*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*
Please note Add-Aspirin will not have telephone access on Friday 6th October but will be responding to emails as normal. Any emergency unblinding should be performed through the trial website on this day.
On 9th October 2017 ICTM and the Add-Aspirin Team will be moving to the new address below:
MRC Clinical Trials Unit at UCL
90 High Holborn 2nd Floor
Any post already sent will be forwarded to the new address, but please send all CRFs to the address above from 9th October onwards. Contact telephone numbers and email addresses will remain the same.
Welcome to our new look website! All features should remain the same, but please do contact us with any feedback.
We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.
Top recruiters: Worcestershire Royal Hospital, Royal Marsden Hospitals, Churchill Hospital Oxford
PARTICIPANTS REGISTERED: 1699
PARTICIPANTS RANDOMISED: 1311
We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer.
Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital
PARTICIPANTS REGISTERED: 961
PARTICIPANTS RANDOMISED: 728
We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).
The Christie, St James's University Hospital, Manor Hospital, Leicester Royal Infirmary
PARTICIPANTS REGISTERED: 115
PARTICIPANTS RANDOMISED: 84
We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.
Top recruiters: UCHW, University Hospital of Wales, Bristol Haematology & Oncology Centre
PARTICIPANTS REGISTERED: 764
PARTICIPANTS RANDOMISED: 594